510(k) Report

510(k) · Cleared

Cleared

DIP/U.S. Urine Analysis Test System

K173327510(k) TraditionalCleared Jul 18, 2018271-day reviewClass II21 CFR 862.1340

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Healthy.Io, Ltd. · JIL Method, Enzymatic, Glucose (Urinary, Non-Quantitative)

Cleared on Jul 18, 2018 as substantially equivalent to K111221 (ACON Laboratories, Inc., 2012) after a 271-day review. Its family tree reaches back 4 generations to 1991.

Decided
Jul 18, 2018
Review
271 days
Class
Class II
Product code
JIL
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K905396 (1991). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK905396 Hemastix Reagent StripsHeraeus Kulzer, Inc. · 1991
  2. 3 generations backK031947 Bayer Clinitek Status AnalyzerBayer Healthcare, LLC · 2003
  3. 2 generations backK070929 Acon U120 Urine Analyzer, Model U111-101ACON Laboratories, Inc. · 2007
  4. 1 generation backK111221 Mission U500 Urine AnalyzerACON Laboratories, Inc. · 2012
  5. This deviceK173327 DIP/U.S. Urine Analysis Test SystemHealthy.Io, Ltd. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K905396Hemastix Reagent StripsHeraeus Kulzer, Inc.1991—
−3K031947Bayer Clinitek Status AnalyzerBayer Healthcare, LLC2003—
−2K070929Acon U120 Urine Analyzer, Model U111-101ACON Laboratories, Inc.2007—
−1K111221Mission U500 Urine AnalyzerACON Laboratories, Inc.2012—
0 (this device)K173327DIP/U.S. Urine Analysis Test SystemHealthy.Io, Ltd.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
199710
199910
FIG. 1 — Lineage of K173327, 1991–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JIL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JIL device

  1. #1 K193514 AUTION MAX AX-4060 Urinalysis Systemscore 6.1 · 4 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K111221Mission U500 Urine Analyzer
Summary page 6
…te device: Manufacturer Device 510(k) Number ACON Laboratories Inc. ACON Mission U500 Urinalysis K111221 System Device Description The DIP | U.S. Urine Analysis Test System consists of a smartph…
ACON Laboratories, Inc.2012—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 4 companies; a new generation was cleared every 6.5 years on median.
  • 1 of the 7 ancestors has a recall of any class.

How does its category compare?

All JIL devices

JIL Method, Enzymatic, Glucose (Urinary, Non-Quantitative): FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · JIL

1in 2023

2007: 32009: 12011: 12012: 12014: 12015: 12016: 22017: 12018: 42019: 12023: 1
2007high 4 (2018) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JIL

187in 2018

2007: 284 days median2018: 187 days median
2007high 284 (2007) · low 187 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JIL

1in 2025

2014: 42016: 12025: 1
2007high 4 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JIL

15in 2025

2007: 202008: 202009: 162010: 112011: 142012: 52013: 322014: 472015: 452016: 402017: 332018: 682019: 672020: 232021: 122022: 142023: 152024: 212025: 15
2007high 68 (2018) · low 5 (2012)2025

MAUDE reports naming product code JIL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20073284020
20080—020
20091—016
20100—011
20111—014
20121—05
20130—032
20141—447
20151—045
20162—140
20171—033
20184187068
20191—067
20200—023
20210—012
20220—014
20231—015
20240—021
20250—115
20260—0—

What is it indicated for?

The DIP | U.S. Urine Analysis Test System consists of a smartphone application, a proprietary Color-Board, and Urinalysis Reagent Strips. It is intended for the semi-quantitative detection of the following analytes in urine: Glucose, Specific Gravity, Blood, pH and Protein, as well as the qualitative detection of Nitrite. The DIP | U.S. Urine Analysis Test System is intended for prescription home-use only, with results provided directly to the physician.…

Read the full statement (139 words)

The DIP | U.S. Urine Analysis Test System consists of a smartphone application, a proprietary Color-Board, and Urinalysis Reagent Strips. It is intended for the semi-quantitative detection of the following analytes in urine: Glucose, Specific Gravity, Blood, pH and Protein, as well as the qualitative detection of Nitrite.

The DIP | U.S. Urine Analysis Test System is intended for prescription home-use only, with results provided directly to the physician. The results can be used to guide patient management and care, and aid in the diagnosis and monitoring of metabolic or systemic diseases that affect kidney function and endocrine disorders. Physician interpretation of the results should be made in conjunction with the patient’s other clinical information to determine if further confirmatory tests or consultations are necessary. Patients do not have access to the results at any point in the process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K173327: DIP/U.S. Urine Analysis Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K173327

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026